NextFerm Technologies（NXFR.M）株式概要フードテック企業であるネクストファーム・テクノロジーズ・リミテッドは、食品業界向けに遺伝子組み換えを行わない酵母ベースの技術や製品の研究、開発、製造、販売を行っている。 詳細NXFR.M ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性1/6配当金0/6報酬過去5年間の収益は年間5.2%増加しました。 リスク分析収益が 100 万ドル未満 ( $147K )意味のある時価総額がありません ( ₪28M )過去1年間で株主の希薄化は大幅に進んだ キャッシュランウェイが1年未満である +1 さらなるリスクすべてのリスクチェックを見るNXFR.M Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₪Current Price₪83.0016.8k% 割高 内在価値ディスカウントEst. Revenue$PastFuture-8m283k2016201920222025202620282031Revenue US$136.6kEarnings US$13.2kAdvancedSet Fair ValueView all narrativesFeatured narrative•Materials opportunityUpside Gold3 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.0% 割安 内在価値ディスカウントAn Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative15.3kusers have viewed this narrative42users have liked this narrative1users have commented on this narrative287users have followed this narrativeRead narrativeNextFerm Technologies Ltd 競合他社Nur Ink InnovationsSymbol: TASE:NURIMarket cap: ₪74.2mBram IndustriesSymbol: TASE:BRAMMarket cap: ₪31.6mPlasto-Cargal GroupSymbol: TASE:PLCRMarket cap: ₪37.6mGinegar Plastic ProductsSymbol: TASE:GNGRMarket cap: ₪99.9m価格と性能株価の高値、安値、推移の概要NextFerm Technologies過去の株価現在の株価₪83.0052週高値₪238.9052週安値₪16.03ベータ2.561ヶ月の変化83.99%3ヶ月変化316.04%1年変化-16.96%3年間の変化-76.65%5年間の変化-99.21%IPOからの変化-99.60%最新ニュースNew Risk • Apr 22New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$124k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.1m free cash flow). Share price has been highly volatile over the past 3 months (72% average daily change). Negative equity (-US$124k). Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$147k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.25m).New Risk • Apr 20New major risk - Revenue and earnings growthEarnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (72% average daily change). Earnings have declined by 0.2% per year over the past 5 years. Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$247k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.30m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).Reported Earnings • Apr 19Full year 2025 earnings released: US$0.21 loss per share (vs US$89.83 loss in FY 2024)Full year 2025 results: US$0.21 loss per share (improved from US$89.83 loss in FY 2024). Revenue: US$147.0k (down 16% from FY 2024). Net loss: US$2.90m (loss narrowed 45% from FY 2024). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings.お知らせ • Jan 21NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026. Location: pearl law offices, IsraelBoard Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent External Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.New Risk • Apr 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.5m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (US$174k revenue). Market cap is less than US$10m (₪7.87m market cap, or US$2.07m).最新情報をもっと見るRecent updatesNew Risk • Apr 22New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$124k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.1m free cash flow). Share price has been highly volatile over the past 3 months (72% average daily change). Negative equity (-US$124k). Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$147k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.25m).New Risk • Apr 20New major risk - Revenue and earnings growthEarnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (72% average daily change). Earnings have declined by 0.2% per year over the past 5 years. Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$247k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.30m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).Reported Earnings • Apr 19Full year 2025 earnings released: US$0.21 loss per share (vs US$89.83 loss in FY 2024)Full year 2025 results: US$0.21 loss per share (improved from US$89.83 loss in FY 2024). Revenue: US$147.0k (down 16% from FY 2024). Net loss: US$2.90m (loss narrowed 45% from FY 2024). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings.お知らせ • Jan 21NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026. Location: pearl law offices, IsraelBoard Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent External Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.New Risk • Apr 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.5m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (US$174k revenue). Market cap is less than US$10m (₪7.87m market cap, or US$2.07m).Reported Earnings • Apr 02Full year 2024 earnings released: US$0.90 loss per share (vs US$0.94 loss in FY 2023)Full year 2024 results: US$0.90 loss per share. Net loss: US$5.32m (loss widened 25% from FY 2023).New Risk • Mar 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 2.4% per year over the past 5 years. Revenue is less than US$1m (US$110k revenue). Market cap is less than US$10m (₪12.2m market cap, or US$3.39m). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Shareholders have been diluted in the past year (21% increase in shares outstanding).New Risk • May 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.7m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 10% per year over the past 5 years. Revenue is less than US$1m (US$283k revenue). Market cap is less than US$10m (₪27.8m market cap, or US$7.57m). Minor Risk Shareholders have been diluted in the past year (5.8% increase in shares outstanding).Reported Earnings • Apr 01Full year 2023 earnings released: US$0.06 loss per share (vs US$0.54 loss in FY 2022)Full year 2023 results: US$0.06 loss per share (improved from US$0.54 loss in FY 2022). Net loss: US$4.25m (loss narrowed 47% from FY 2022).New Risk • Mar 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$7.2m free cash flow). Earnings have declined by 16% per year over the past 5 years. Revenue is less than US$1m (US$384k revenue). Market cap is less than US$10m (₪20.9m market cap, or US$5.82m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (7.6% average weekly change).Reported Earnings • Aug 22First half 2023 earnings released: US$0.04 loss per share (vs US$0.23 loss in 1H 2022)First half 2023 results: US$0.04 loss per share (improved from US$0.23 loss in 1H 2022). Net loss: US$2.29m (loss narrowed 34% from 1H 2022).Reported Earnings • Mar 26Full year 2022 earnings released: US$0.54 loss per share (vs US$0.49 loss in FY 2021)Full year 2022 results: US$0.54 loss per share (further deteriorated from US$0.49 loss in FY 2021). Net loss: US$8.07m (loss widened 47% from FY 2021).Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.分析記事 • May 19We Think NextFerm Technologies (TLV:NXFR) Can Afford To Drive Business GrowthEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: US$0.49 (up from US$1.87 loss in FY 2020). Net loss: US$5.51m (loss widened 37% from FY 2020). Revenue was in line with analyst estimates.分析記事 • Jan 02Here's Why We're Watching NextFerm Technologies' (TLV:NXFR) Cash Burn SituationWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...お知らせ • Jul 15NextFerm Technologies Ltd Obtains Regulatory Approval to Market Astaferm Astaxanthin Antioxidant in CanadaNextFerm Technologies Ltd. announced that Health Canada has granted a regulatory marketing approval for Astaferm(R), its innovative fermented astaxanthin antioxidant in the form of Gummies. This is the only fermented astaxanthin with no odor and flavor. Along with the receipt of Astaferm(R)'s license approval (NPN - Natural Product Number), the company is preparing for the launch of several applications of Astaferm(R) in North America, including for Immunity support, which is a growing segment due to the Covid-19 pandemic. The Company has already supplied initial quantities of Astaferm(R) in Canada and is currently in dialogues with potential customers. Astaferm(R) has a US Self GRAS regulatory approval and was launched in the US at the end of 2020. The product is in early stages of sales, by well-known US dietary supplement brands, such as Carlson Labs and Purity Products. Since Astaferm(R) is flavorless and odorless, the Gummies application constitutes a significant differentiation from other astaxanthin products available on the market, produced from algae with fishy odor, and therefore applied mainly in soft-gels. NextFerm currently prepares to expand the marketing of Astaferm(R) for additional indications such as immune system support, as well as expanding into additional serving forms, such as water-dispersible powder for food and beverages, and fermented Astaferm(R) oil for soft-gels with competitive pricing.分析記事 • Jul 08We Think NextFerm Technologies (TLV:NXFR) Can Afford To Drive Business GrowthJust because a business does not make any money, does not mean that the stock will go down. For example, although...株主還元NXFR.MIL ChemicalsIL 市場7D-0.3%8.5%3.6%1Y-17.0%20.3%56.2%株主還元を見る業界別リターン: NXFR.M過去 1 年間で20.3 % の収益を上げたIL Chemicals業界を下回りました。リターン対市場: NXFR.Mは、過去 1 年間で56.2 % のリターンを上げたIL市場を下回りました。価格変動Is NXFR.M's price volatile compared to industry and market?NXFR.M volatilityNXFR.M Average Weekly Movementn/aChemicals Industry Average Movement5.5%Market Average Movement5.4%10% most volatile stocks in IL Market8.7%10% least volatile stocks in IL Market3.7%安定した株価: データは利用できません。時間の経過による変動: 過去 1 年間のNXFR.Mのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト201311n/awww.nextferm.comフードテック企業であるネクストファーム・テクノロジーズ・リミテッドは、食品産業向けに遺伝子組み換えを行わない酵母ベースの技術や製品の研究、開発、生産、販売を行っている。ヴィーガンタンパク質ProteVin、発酵アスタキサンチンAstaferm、様々な凍結融解サイクルに耐える酵母製品NextFreeze、コーンメッシュからエタノールを生産するための新規酵母株Biofuelを提供している。同社は2013年に法人化され、イスラエルのヨクネアムに本社を置いている。もっと見るNextFerm Technologies Ltd 基礎のまとめNextFerm Technologies の収益と売上を時価総額と比較するとどうか。NXFR.M 基礎統計学時価総額₪28.04m収益（TTM）-₪8.41m売上高(TTM)₪426.49k65.8xP/Sレシオ-3.3xPER（株価収益率NXFR.M は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計NXFR.M 損益計算書（TTM）収益US$147.00k売上原価US$363.00k売上総利益-US$216.00kその他の費用US$2.68m収益-US$2.90m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-8.58グロス・マージン-146.94%純利益率-1,972.79%有利子負債／自己資本比率0%NXFR.M の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/10 08:16終値2026/05/05 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋NextFerm Technologies Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Featured narrative•Materials opportunityUpside Gold3 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.0% 割安 内在価値ディスカウントAn Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative15.3kusers have viewed this narrative42users have liked this narrative1users have commented on this narrative287users have followed this narrativeRead narrative
New Risk • Apr 22New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$124k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.1m free cash flow). Share price has been highly volatile over the past 3 months (72% average daily change). Negative equity (-US$124k). Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$147k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.25m).
New Risk • Apr 20New major risk - Revenue and earnings growthEarnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (72% average daily change). Earnings have declined by 0.2% per year over the past 5 years. Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$247k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.30m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
Reported Earnings • Apr 19Full year 2025 earnings released: US$0.21 loss per share (vs US$89.83 loss in FY 2024)Full year 2025 results: US$0.21 loss per share (improved from US$89.83 loss in FY 2024). Revenue: US$147.0k (down 16% from FY 2024). Net loss: US$2.90m (loss narrowed 45% from FY 2024). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings.
お知らせ • Jan 21NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026. Location: pearl law offices, Israel
Board Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent External Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
New Risk • Apr 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.5m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (US$174k revenue). Market cap is less than US$10m (₪7.87m market cap, or US$2.07m).
New Risk • Apr 22New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$124k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.1m free cash flow). Share price has been highly volatile over the past 3 months (72% average daily change). Negative equity (-US$124k). Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$147k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.25m).
New Risk • Apr 20New major risk - Revenue and earnings growthEarnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (72% average daily change). Earnings have declined by 0.2% per year over the past 5 years. Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Revenue is less than US$1m (US$247k revenue). Market cap is less than US$10m (₪12.8m market cap, or US$4.30m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
Reported Earnings • Apr 19Full year 2025 earnings released: US$0.21 loss per share (vs US$89.83 loss in FY 2024)Full year 2025 results: US$0.21 loss per share (improved from US$89.83 loss in FY 2024). Revenue: US$147.0k (down 16% from FY 2024). Net loss: US$2.90m (loss narrowed 45% from FY 2024). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings.
お知らせ • Jan 21NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026NextFerm Technologies Ltd, Annual General Meeting, Feb 25, 2026. Location: pearl law offices, Israel
Board Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent External Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
New Risk • Apr 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.5m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 0.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (US$174k revenue). Market cap is less than US$10m (₪7.87m market cap, or US$2.07m).
Reported Earnings • Apr 02Full year 2024 earnings released: US$0.90 loss per share (vs US$0.94 loss in FY 2023)Full year 2024 results: US$0.90 loss per share. Net loss: US$5.32m (loss widened 25% from FY 2023).
New Risk • Mar 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 2.4% per year over the past 5 years. Revenue is less than US$1m (US$110k revenue). Market cap is less than US$10m (₪12.2m market cap, or US$3.39m). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Shareholders have been diluted in the past year (21% increase in shares outstanding).
New Risk • May 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.7m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 10% per year over the past 5 years. Revenue is less than US$1m (US$283k revenue). Market cap is less than US$10m (₪27.8m market cap, or US$7.57m). Minor Risk Shareholders have been diluted in the past year (5.8% increase in shares outstanding).
Reported Earnings • Apr 01Full year 2023 earnings released: US$0.06 loss per share (vs US$0.54 loss in FY 2022)Full year 2023 results: US$0.06 loss per share (improved from US$0.54 loss in FY 2022). Net loss: US$4.25m (loss narrowed 47% from FY 2022).
New Risk • Mar 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$7.2m free cash flow). Earnings have declined by 16% per year over the past 5 years. Revenue is less than US$1m (US$384k revenue). Market cap is less than US$10m (₪20.9m market cap, or US$5.82m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (7.6% average weekly change).
Reported Earnings • Aug 22First half 2023 earnings released: US$0.04 loss per share (vs US$0.23 loss in 1H 2022)First half 2023 results: US$0.04 loss per share (improved from US$0.23 loss in 1H 2022). Net loss: US$2.29m (loss narrowed 34% from 1H 2022).
Reported Earnings • Mar 26Full year 2022 earnings released: US$0.54 loss per share (vs US$0.49 loss in FY 2021)Full year 2022 results: US$0.54 loss per share (further deteriorated from US$0.49 loss in FY 2021). Net loss: US$8.07m (loss widened 47% from FY 2021).
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
分析記事 • May 19We Think NextFerm Technologies (TLV:NXFR) Can Afford To Drive Business GrowthEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Suzana Nahum-Zilberberg was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: US$0.49 (up from US$1.87 loss in FY 2020). Net loss: US$5.51m (loss widened 37% from FY 2020). Revenue was in line with analyst estimates.
分析記事 • Jan 02Here's Why We're Watching NextFerm Technologies' (TLV:NXFR) Cash Burn SituationWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
お知らせ • Jul 15NextFerm Technologies Ltd Obtains Regulatory Approval to Market Astaferm Astaxanthin Antioxidant in CanadaNextFerm Technologies Ltd. announced that Health Canada has granted a regulatory marketing approval for Astaferm(R), its innovative fermented astaxanthin antioxidant in the form of Gummies. This is the only fermented astaxanthin with no odor and flavor. Along with the receipt of Astaferm(R)'s license approval (NPN - Natural Product Number), the company is preparing for the launch of several applications of Astaferm(R) in North America, including for Immunity support, which is a growing segment due to the Covid-19 pandemic. The Company has already supplied initial quantities of Astaferm(R) in Canada and is currently in dialogues with potential customers. Astaferm(R) has a US Self GRAS regulatory approval and was launched in the US at the end of 2020. The product is in early stages of sales, by well-known US dietary supplement brands, such as Carlson Labs and Purity Products. Since Astaferm(R) is flavorless and odorless, the Gummies application constitutes a significant differentiation from other astaxanthin products available on the market, produced from algae with fishy odor, and therefore applied mainly in soft-gels. NextFerm currently prepares to expand the marketing of Astaferm(R) for additional indications such as immune system support, as well as expanding into additional serving forms, such as water-dispersible powder for food and beverages, and fermented Astaferm(R) oil for soft-gels with competitive pricing.
分析記事 • Jul 08We Think NextFerm Technologies (TLV:NXFR) Can Afford To Drive Business GrowthJust because a business does not make any money, does not mean that the stock will go down. For example, although...
